share_log

TD Cowen Maintains Outperform on Novo Nordisk, Raises Price Target to $115

Benzinga ·  Dec 4, 2023 12:27

TD Cowen analyst Michael Nedelcovych maintains Novo Nordisk (NYSE:NVO) with a Outperform and raises the price target from $105 to $115.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment